Risk factor
Strong & resilient to price shocks
Profitability factor
Good growth
About
Rede D'Or São Luiz S.A. manages an extensive healthcare network across Brazil. The company delivers a comprehensive range of medical services, covering areas such as neurology, oncology, and pathology, alongside specialized treatments for hemangioma, lymphangioma, lymphatic malformation, and various vascular anomalies and tumors. Its offerings also include advanced vascular surgery, radiology, and interventional radiology. For younger patients, it provides expert care in pediatric cardiology, oncology, hematology, and surgery. This extensive enterprise comprises 51 wholly-owned hospitals, one managed hospital, and 47 oncology clinics, housing a total of 9,000 beds. Complementary services like blood banks, dialysis centers, and diverse specialized outpatient clinics are also part of its portfolio. Notably, Rede D'Or is equipped with robot surgery facilities across Brazil. Its geographical footprint extends to the states of Rio de Janeiro, São Paulo, Pernambuco, Bahia, Maranhão, Sergipe, Ceará, Paraná, and the Federal District. Founded in 1977, with its headquarters in São Paulo, Brazil, the company was previously known as Hospital Maternidade São Luiz S.A.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value
Target Price
The average target price of RDOR3.SA is 49.3 and suggests 31.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to